PUBLICATIONS · 28972430
Life after ponatinib failure: outcomes of chronic and accelerated phase CML patients who discontinued ponatinib in the salvage setting.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Leuk Lymphoma
- Publication date
- 2018 Jun
- First author
- Boddu P
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Boddu P
- type
- Author
- name
- Shah AR
- type
- Author
- name
- Borthakur G
- type
- Author
- name
- Verstovsek S
- type
- Author
- name
- Garcia-Manero G
- type
- Author
- name
- Daver N
- type
- Author
- name
- Kadia T
- type
- Author
- name
- Ravandi F
- type
- Author
- name
- Jain N
- type
- Author
- name
- Alhuraiji A
- type
- Author
- name
- Burger J
- type
- Author
- name
- Kornblau S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Boddu P
- type
- Author
- name
- Shah AR
- type
- Author
- name
- Borthakur G
- type
- Author
- name
- Verstovsek S
- type
- Author
- name
- Garcia-Manero G
- type
- Author
- name
- Daver N
- type
- Author
- name
- Kadia T
- type
- Author
- name
- Ravandi F
- type
- Author
- name
- Jain N
- type
- Author
- name
- Alhuraiji A
- type
- Author
- name
- Burger J
- type
- Author
- name
- Kornblau S
- type
- Author
- bibliography ids
- nci-bib-aed012e73ddf5eba2347c8b3
- book metadata
- content sha256
- 7aeab40bf3d19743cccee58358bcb79596b2f0c8b3675524bc56d35d6b8a3f53
- document type
- citation
- dois
- 10.1080/10428194.2017.1379076
- electronic publication date
- display
- 2017 Oct 3
- precision
- day
- year
- 2017
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:28972430
- immutable id
- pubmed:28972430@7aeab40bf3d19743cccee58358bcb79596b2f0c8b3675524bc56d35d6b8a3f53
- journal
- abbreviation
- Leuk Lymphoma
- issn electronic
- 1029-2403
- issn print
- 1042-8194
- issue
- 6
- name
- Leukemia & lymphoma
- nlm unique id
- 9007422
- pages
- 1312-1322
- volume
- 59
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 28972430
- provenance
- batch id
- fb25b16edcb1373b70c1
- provider
- NCBI PubMed ESummary
- record sha256
- 68035192994d4234507f16853753e307a68af552040db01c8ad301bd4a0f2c03
- response sha256
- 182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
- retrieved at
- 2026-09-09T23:47:28.490065+00:00
- publication date
- display
- 2018 Jun
- precision
- month
- year
- 2018
- publication types
- Journal Article
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Life after ponatinib failure: outcomes of chronic and accelerated phase CML patients who discontinued ponatinib in the salvage setting.
Preserved source evidence · Not medical advice
Triangle